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Introduction
The ER is a large organelle that spreads throughout the cyto-
plasm as a continuous network of tubules and sheets with a sin-
gle lumen (Baumann and Walz, 2001; English et al., 2009). The 
interconnected ER network is constantly reorganizing its struc-
ture as new ER tubules grow out of existing ones, old tubules 
retract, sheets move, and new junctions are formed by fusion 
between ER membranes (Lee and Chen, 1988; Waterman-Storer 
and Salmon, 1998). Remarkably, the ER remains continuous 
throughout these reorganizations and maintains a resemblance 
of its original characteristic shape (Fig. 1 A). The ER is a dy-
namic organelle throughout the cell cycle in all organisms that 
have been imaged, yet it is still unclear whether ER dynamics 
play a critical role in ER functions, including protein secretion, 
lipid synthesis, and calcium regulation.
In animal cells, dynamic ER tubules coalign with micro-
tubules (MTs), and ER dynamics are altered by depolymeriza-
tion of MTs by cold-shock or the drug nocodazole (Terasaki 
et al., 1986; Waterman-Storer and Salmon, 1998). There are two 
mechanistically distinct ways that ER tubules can be visualized 
moving along MTs. The first mechanism is referred to as tip 
attachment complex (TAC) dynamics and describes the situation 
where the tip of the ER tubule appears attached to the tip of the 
MT plus end. During TAC, the ER tubule grows or retracts as   
its MT partner grows or retracts. TAC rearrangements occur on 
MTs that are dynamic and highly sensitive to nocodazole treat-
ment (Waterman-Storer and Salmon, 1998). TAC rearrangements 
are dependent on an ER protein, STIM1, and an MT plus end–
binding protein, EB1 (Grigoriev et al., 2008). STIM1 is also   
involved in calcium handling (Liou et al., 2007), but a link between 
these two functions has not been shown (Grigoriev et al., 
2008), and the function of TAC remains undetermined.
The second mechanism of ER tubule dynamics is referred to 
as sliding, whereby the tip of the ER tubule initially binds to the 
shaft of an existing MT and slides along the MT as the ER tubule 
grows (Lee and Chen, 1988; Waterman-Storer and Salmon, 1998). 
Sliding does not correlate with MT growth or shrinkage. Sliding is 
less sensitive to nocodazole depolymerization of MTs than TAC 
(Waterman-Storer and Salmon, 1998), and its frequency is not   
affected by depletion of STIM1 or EB1 (Grigoriev et al., 2008).   
In addition, ER tubule sliding events are much more frequent and 
T
he endoplasmic reticulum (ER) network is extremely 
dynamic in animal cells, yet little is known about the 
mechanism and function of its movements. The most 
common ER dynamic, termed ER sliding, involves ER tu-
bule extension along stable microtubules (MTs). In this study, 
we  show  that  ER  sliding  occurs  on  nocodazole-resistant   
MTs that are posttranslationally modified by acetylation. 
We demonstrate that high MT curvature is a good indica-
tor of MT acetylation and show in live cells that ER sliding 
occurs predominantly on these curved, acetylated MTs. 
Furthermore, increasing MT acetylation by drug treatment 
increases the frequency of ER sliding. One purpose of the 
ER sliding on modified MT tracts could be to regulate its 
interorganelle  contacts.  We  find  that  all  mitochondria   
and many endosomes maintain contact with the ER de-
spite the movements of each. However, mitochondria, 
but not endosomes, preferentially localize to acetylated 
MTs. Thus, different ER dynamics may occur on distinct MT 
populations to establish or maintain contacts with differ-
ent organelles.
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Figure 1.  ER sliding events occur on a nocodazole-resistant population of MTs, which is consistent with MT acetylation. (A) Merged image of COS-7 cell 
expressing GFP–Sec61- at t = 0 (green) and t = 30 s (red). Arrows indicate an unchanged ER position (yellow), a new sliding event (white), or a position 
of ER rearrangement (blue; see Video 1). (B) Examples of a TAC and sliding event (top and bottom panel, respectively). Dynamic events were captured 
by coexpressing mCherry–-tubulin (red) and either YFP-STIM1 (TAC; green) or GFP–Sec61- (sliding; green). Images shown are 10 s or 40 s apart for 
TAC versus sliding, respectively. Arrows indicate ER movement. (C) Graph of speed of TAC (n = 10) versus sliding events (n = 30). **, P = 4.3 × 10
10; 
unpaired t test. (D) Number of sliding events longer than 1 µm in a 10 × 10–µm region during 5 min before and 15–20 min after 5 µM nocodazole treat-
ment (n = 4 cells; see Videos 2 and 3). (E) Number of TAC events as in D in four different YFP-STIM1–expressing cells. (F) Example of an ER sliding event 
in a GFP–Sec61-– and mCherry–-tubulin–expressing cell 15 min after nocodazole treatment. Arrows depict the movement of an ER tubule along an MT. 
(G) Immunofluorescence staining of -tubulin and acetylated tubulin in cells treated for 0, 5, 10, and 20 min with 5 µM nocodazole (NZ) before fixation. 
(H) Graph of the percentage of MTs containing acetylation staining over half of its length or >5 µm of its length at various times of nocodazole treatment 
(n = 3 cells per time point). (C and H) Error bars show standard deviation. Bars: (A and G) 10 µm; (B and F) 1 µm.365 ER dynamics occur on acetylated microtubules • Friedman et al.
with the MT plus end tip (Fig. 1 B, top; Grigoriev et al., 2008). 
Sliding events were those whereby an ER tubule was initially 
bound to the MT shaft and slid along its length as the ER   
tubule extends (Fig. 1 B, bottom). We measured the relative 
speed and frequency of TAC versus sliding events and found 
that sliding was 10-fold faster than TAC (0.485 ± 0.264 µm/s 
vs. 0.044 ± 0.018 µm/s; Fig. 1 C), similar to data from HeLa 
cells (Grigoriev et al., 2008). Thus, TAC and sliding events dif-
fer in their speed of movement along MT tracts.
How do cells accomplish two mechanisms of ER motility? 
One possibility is that the two mechanisms occur on distinct MT 
populations. ER sliding dynamics were previously shown to be less 
sensitive than TAC dynamics to MT depolymerization with low 
levels of nocodazole (100 nM) in newt lung cells (Waterman-Storer 
and Salmon, 1998). We tested whether ER sliding in mammalian 
COS-7 cells is also less sensitive to 5 µM nocodazole. We mea-
sured the number of sliding or TAC events during 5-min windows 
before nocodazole treatment and 15–20 min after treatment (in a 
10 × 10–µm box in the peripheral ER; Fig. 1, D and E; and Videos 
2 and 3). We found that TAC events >1 µm in length ceased by 
15 min after nocodazole treatment (Fig. 1 E). In contrast, sliding 
events decreased by <50% by 15–20 min after treatment (Fig. 1, 
D and F). By 60–65 min after treatment, ER sliding was nearly 
abolished. These results indicate that TAC events occur on dy-
namic MTs that are sensitive to nocodazole, whereas sliding events 
occur on MTs that are resistant to nocodazole.
Nocodazole-resistant MTs have been defined as the stable 
MTs, and this population has been shown to be marked by acety-
lation on lysine-40 of -tubulin in 3T3 cells and rat astrocytes 
(Piperno et al., 1987; Cambray-Deakin et al., 1988). To quantify 
the correlation between nocodazole resistance and acetylation 
in COS-7 cells, the cells were treated with 5 µM nocodazole for 
increasing lengths of time, fixed, and stained with antibodies to 
both -tubulin and acetylated -tubulin, and the percentage 
of MTs that were acetylated was determined from the merged 
images. Our analyses focused on regions of the cell periphery 
where individual MTs could be resolved, and we counted an 
acetylated MT as one whose length appeared >50% acetylated 
or which contained >5 µm of acetylation staining (an arbitrary 
fluorescence intensity was used as a cutoff). At t = 0 (before   
nocodazole), only 17% of the MTs in the periphery appeared 
heavily acetylated (Fig. 1 G, left). Nocodazole treatment led 
to a dramatic and rapid reduction in the total number of MTs 
(Fig. 1 G, compare t = 0 with t = 10 min). Quite strikingly, of the 
MTs remaining at 10 min and 20 min after treatment, almost 
all were positive for acetylation (80% and 95%, respectively; 
Fig. 1 H). Therefore, acetylation marks a nocodazole-resistant 
population of MTs in COS-7 cells. Because sliding events are 
also resistant to nocodazole, collectively, these data suggest that 
ER sliding dynamics, and not TAC events, may preferentially 
occur on the subpopulation of MTs that are acetylated.
ER sliding events occur on acetylated 
regions of MTs
To directly test whether ER sliding occurs on acetylated MTs, 
we imaged live COS-7 cells that were cotransfected with GFP–
Sec61- and mCherry–-tubulin on gridded coverslips and 
faster than TAC dynamics (Waterman-Storer and Salmon, 1998; 
Grigoriev et al., 2008). ER sliding occurs in both directions along 
MTs (Waterman-Storer and Salmon, 1998) and is thought to be 
driven by the MT-based motor proteins cytoplasmic dynein and 
kinesin-1 (Woźniak et al., 2009). No ER proteins have been identi-
fied that are responsible for ER sliding dynamics.
Why does the ER adopt a reticular network that is spread 
throughout the cell and why is this huge membrane-bound com-
partment constantly rearranging? Why do cells require two 
mechanisms to accomplish this? The ER contacts many other 
membrane-bound compartments in the cell, including mito-
chondria, lysosomes, Golgi, and the plasma membrane (Levine 
and Loewen, 2006; English et al., 2009). These interactions are 
functionally important for both lipid biosynthesis (Vance, 2008) 
and calcium signaling in animal cells (Csordás et al., 2006;   
de Brito and Scorrano, 2008) and may also be important for fa-
cilitating lipid transport. Because sliding and TAC are two mecha-
nisms mediated by different factors and occurring at different 
rates, these mechanisms are likely important for different ER 
functions. To test how ER dynamics affect ER function, we 
must first understand which factors are involved.
In this study, we show that ER sliding occurs on stable MTs 
that have been posttranslationally modified by acetylation of   
-tubulin subunits. In contrast, TAC occurs only on dynamic, 
nonacetylated, MTs. We propose that one reason that ER sliding 
occurs on acetylated MTs is to limit its distribution on defined 
paths within the cytoskeleton so that it can generate organelle con-
tacts. We demonstrate that mitochondria, but not endosomes, are 
also preferentially found to colocalize with acetylated MTs. To-
gether, these data suggest that ER sliding on acetylated MTs does 
not contribute to all interorganelle contacts; different organelles   
appear to rely on different MT modifications to contact the ER.
Results
TAC and sliding are unique mechanisms for 
ER travel along distinct populations of MTs
The ER network maintains a resemblance of its overall shape 
over time while constantly reorganizing its network of tubules 
and sheets. This is achieved in part by ER tubules growing, 
shrinking, and rearranging. These dynamics can be visualized 
by  live  imaging  of  COS-7  cells  expressing  the  general  ER 
marker GFP–Sec61- (Fig. 1 A and Video 1). When images of 
the ER at different time points are merged (e.g., t = 0 [green] 
and t = 30 s [red] in Fig. 1 A), new tubules that formed during 
the 30-s time period are visualized in red (Fig. 1 A, white arrow), 
whereas  ER  regions  remaining  unchanged  appear  yellow   
(Fig. 1 A, yellow arrow). Regions where the ER has shifted or 
rearranged appear as green tubules in proximity to red ones 
(Fig. 1 A, blue arrow).
To address the mechanisms of MT-dependent ER dynam-
ics, we first characterized the differences between tubule dy-
namics by TAC versus sliding. Cells were cotransfected with 
mCherry–-tubulin (to visualize MTs) and either YFP-STIM1 
(Liou et al., 2005; to mark ER TAC events) or GFP–Sec61- (to 
visualize all ER dynamics). TAC events were those where the 
tip of the ER tubule was labeled with YFP-STIM1 and colocalized JCB • VOLUME 190 • NUMBER 3 • 2010   366
ability to track single sliding events. Therefore, we focused on 
the periphery, where single ER sliding events are well resolved 
and can be retrospectively identified. In the periphery, many 
MTs  have  short  stretches  that  stain  positive  for  acetylation, 
which we refer to as acetylated patches.
As shown in Fig. 2 (A and B), ER sliding events along 
MTs (left) corresponded to regions along MTs that labeled pos-
itive for acetylation (right; for staining of entire cell, see Fig. S1). 
These events were identified because the ER and MTs were well 
quickly fixed the cells to preserve ER and MT structure. We 
then performed immunolabeling with antibodies to -tubulin 
and acetylated -tubulin and fluorescent secondary antibodies. 
The gridded coverslips allowed us to retrospectively identify 
the same cell that we imaged live.
Acetylation levels are not constant throughout the cell; the 
cell center contains more acetylated MTs than the periphery 
(Fig. S1). Likewise, the ER is most dense and the most dynamic 
in the perinuclear region. Yet, this density interferes with our 
Figure 2.  Retrospective imaging demonstrates ER dynamics that occur on acetylated MTs. (A–D, left) ER sliding events were captured during live cell imag-
ing of cells expressing GFP–Sec61- and mCherry–-tubulin at the times indicated (in seconds). (right) Cells were then fixed and stained with antibody 
to -tubulin and acetylated -tubulin and reimaged. Merged images are shown with the indicated colors. (A and B) Examples of ER sliding on MTs with 
homogeneous acetylation staining. Sliding event progression during live imaging is marked with arrows for the starting position (white) and for end position 
(yellow). (C) An example of ER sliding from starting position (white arrows) to a patch of acetylation (yellow arrows) and retracting to a second acetylation 
patch (blue arrows). (D) An example of a sliding event, followed by an ER dynamic that leads to a ring formation (dashed triangles) around an acetylated 
MT patch. Bars, 1 µm.367 ER dynamics occur on acetylated microtubules • Friedman et al.
To measure the curvature of acetylated versus nonacetylated MTs, 
cells were fixed and immunolabeled with antibodies to both 
-tubulin and acetylated -tubulin (Fig. 3 A). For quantifica-
tion, we drew a line through a region of the cell periphery where 
individual MTs can be resolved and where the maximum num-
ber of heavily acetylated MTs appeared. For each acetylated 
and nonacetylated MT along that line (an arbitrary fluorescence 
intensity was used as a cutoff), the mean radius of curvature was 
calculated for a stretch 2.5 µm on each side of the line (Fig. S2 A) 
using the “imodcurvature” program from IMOD (Kremer et al., 
1996). The radius of curvature at a point along a curve can be 
approximated by the radius of a circle that is fit to points along 
the curve (Bicek et al., 2007). For simplification, we will refer 
to the inverse of the mean radius of curvature as curvature. As 
seen in Fig. 3 B, the more curved an MT is, the smaller the ra-
dius of the circle and the larger the curvature will be.
We found that acetylated MTs have a significantly larger   
curvature (more than twofold greater) than nonacetylated MTs 
(244.6 µm
1 vs. 118.5 µm
1; n = 37; P = 3.7 × 10
7; Fig. 3 C, left). 
However, more telling is the relative number of acetylated MTs 
that are highly curved. Only 3% of nonacetylated MTs counted had 
a curvature >250 µm
1, whereas 51% of acetylated MTs had such 
a curvature (Fig. 3 C, right). These data suggest that MT curvature 
is a good indication for whether an MT is acetylated and provide a 
new method to predict MT acetylation in live cells.
resolved in that region of the cell, the sliding event clearly took 
place on a specific MT, the ER and MTs remained relatively 
static in place between the sliding event and fixation, and finally, 
MT acetylation staining was clearly positive for those examples. 
ER sliding events that occurred on acetylated MTs were also 
observed to undergo retractions (Fig. 2 C) as well as rearrange-
ments into rings (Fig. 2 D).
Overall, the retrospective staining data suggest that ER 
sliding correlates with acetylation of the MT tracts. Quite strik-
ingly, these events occurred on acetylated MT patches in a re-
gion of the cell periphery where acetylation is generally sparser. 
However, the inherent difficulties in retrospective imaging, in-
cluding fixation and antibody access to antigen, as well as the 
uncertainties of how much signal constitutes an acetylated MT 
led us to develop a method for correlating the subpopulation of 
MTs that are acetylated with ER sliding in live cells.
Both MT acetylation and ER sliding 
correlate with MT curvature
While imaging acetylated MTs in cells treated with nocodazole 
(Fig. 1 G), we noticed that acetylated MTs appear much more 
curved than nonacetylated MTs. We reasoned that if ER sliding 
occurs preferentially on acetylated MTs and acetylated MTs are 
highly curved relative to nonacetylated ones, ER sliding should 
also occur at a higher frequency on MTs with high curvature. 
Figure 3.  Acetylated MTs and ER sliding events correlate with MT curvature. (A) Immunofluorescence staining of -tubulin and acetylated -tubulin on 
untreated cells. (B) Diagram of curvature. (C, left) Graph of curvature of acetylated (n = 37) or nonacetylated MTs (n = 37). Acetylated MTs were picked 
by drawing a line through the cell at a point containing the maximum number of acetylated MTs. -Tubulin staining of MTs that were not acetylated were 
picked along that line if they were isolated at the line. The mean curvature of the MT for 2.5 µm on either side of the line (or 5 µm total) was determined 
by “imodcurvature.” (right) The frequency of MT curvature in groups of indicated values for nonacetylated MTs or acetylated MTs. (D) Curvature measure-
ments for dynamic MTs (labeled with EB3; n = 37), TAC MTs (labeled with YFP-STIM1; n = 16), and ER sliding MTs (GFP–Sec61-; n = 41). Right panel 
shows frequency of each event. (C and D) Error bars show standard deviation. P-values were determined by unpaired t test: **, P = 3.7 × 10
7 (C); and 
**, P < 0.001 (D). Bar, 10 µm.JCB • VOLUME 190 • NUMBER 3 • 2010   368
Figure 4.  Hyperacetylation of MTs by drug treatment increases ER sliding but not TAC events. (A) COS-7 cells were fixed and immunofluorescently labeled 
with -tubulin and acetylated -tubulin after treatment with 125 nM TSA for 0, 30, 60, and 90 min. (B) COS-7 whole-cell lysate from cells treated for 0, 30, 
60, and 90 min with 125 nM TSA were immunoblotted (IB) with antibodies to acetylated -tubulin and -tubulin. (C) Number of sliding events longer than 369 ER dynamics occur on acetylated microtubules • Friedman et al.
1 µm in a 10 × 10–µm region during 5-min period before and 30–35 and 60–65 min after treatment with 125 nM TSA (n = 4 different GFP–Sec61-– 
expressing cells; see Videos 4 and 5). (D) Number of TAC events, as in C, in four different YFP-STIM1–expressing cells. (E) Graph of the curvature of ER sliding 
events (GFP–Sec61-) from 60–90 min after 125 nM TSA treatment (n = 30) as compared with ER sliding curvature from Fig. 3 and the curvature of a 
representative population of MTs from a cell treated for 60 min with TSA (n = 35). Error bars show standard deviation. P-value was determined by unpaired 
t test: **, P < 0.001. (F) As in A, cells were treated for 0, 1, and 6 h with TSA. (G–I) As in A–C for cells treated with 10 µM tubacin. Bars, 10 µm.
 
To correlate ER sliding events with MT curvature, we 
took live-cell videos of cells cotransfected with the ER marker 
GFP–Sec61- and mCherry–-tubulin and measured the curva-
ture of MTs for sliding events that were longer than 2 µm. The 
mean curvature of these sliding events was 314.9 µm
1 (n = 41), 
and 56% of these events had a curvature >250 µm
1 (Fig. 3 D and 
Fig. S2 B). For comparison, we calculated the curvature of either 
dynamic MTs marked with the MT +TIP protein mCherry-EB3 
(Stepanova et al., 2003) or mCherry–-tubulin–labeled MTs 
that grew with the TAC ER protein YFP-STIM1. Dynamic MTs 
marked with EB3 had a mean curvature of 97.2 µm
1 (n = 37), and 
TAC events traveled on MTs with a mean curvature of 88.2 µm
1 
(n = 16), which are both significantly lower than the curvature 
of MTs with sliding events (P = 1.7 × 10
7 and P = 8.4 × 10
8, 
respectively). These data suggest that ER sliding occurs along 
MTs that are acetylated and have a high curvature.
Increasing MT acetylation by drug 
treatment increases ER sliding
If ER sliding preferentially occurs on acetylated MTs, increas-
ing the number of MTs that are acetylated should increase the 
number of ER sliding events. To test this, we added trichostatin A 
(TSA; at 125 nM), a drug which is a general inhibitor of the 
HDAC (histone deacetylase) family of deacetylases, including 
HDAC6 (Koeller et al., 2003). HDAC6 is a cytoplasmic deacety-
lase responsible for removing the acetylation modification from 
MTs (Hubbert et al., 2002; Reed et al., 2006). Cells were treated 
for increasing amounts of time with TSA, fixed, and immuno-
labeled with antibodies to fluorescently label -tubulin and acety-
lated -tubulin (Fig. 4 A). By 30 min after TSA treatment, 
acetylation staining marked almost all of the MTs in the cell. 
This corresponds to the increase in the levels of acetylated   
tubulin seen by immunoblotting (Fig. 4 B, top). Note that the 
overall levels of -tubulin did not change (Fig. 4 B, bottom).
We then measured whether the increase in MT acetylation 
corresponded to an increase in sliding events; we counted the 
number of sliding events >1 µm in length in a 10 × 10–µm box 
during a 5-min period before treatment and 30–35 and 60–65 min 
after TSA treatment. In each case, the number of sliding events 
in the region increased two- to fourfold between 0 and 60 min 
(n = 4 different cells; Fig. 4 C and Videos 4 and 5). As a control, 
we  tested  whether  the  number  of TAC  events,  marked  with 
YFP-STIM1, increased after TSA treatment. In contrast to slid-
ing, the frequency of TAC events longer than 1 µm in four cells 
decreased over the same period of TSA treatment (Fig. 4 D). The 
increased amount of sliding that occurs after TSA treatment 
provides a direct link between ER sliding events and the level   
of MT acetylation in the cell.
Because under normal conditions acetylated MTs are more 
curved than nonacetylated MTs (Fig. 3 C), we predicted that the 
hyperacetylated MTs generated by TSA treatment would also be 
curved. However, hyperacetylation does not cause an increase in 
overall levels of MT curvature (Fig. 4, A and E). Because TSA 
treatment causes MTs that were previously nonacetylated and 
straight to become acetylated and straight, we can then ask 
whether ER sliding after TSA treatment occurs at a higher rate 
on straight MTs. To test this, we imaged sliding events between 
60 and 90 min after TSA treatment and measured the curvature 
of the MTs from these events. Indeed, the mean curvature of 
sliding events in TSA-treated cells was 114.4 µm
1 (n = 30; 
Fig. 4 E and Fig. S2 C), which is significantly different from the 
curvature of sliding events from untreated cells measured in 
Fig. 3 (314.9 µm
1; P = 1.0 × 10
6).
To test whether the curvature of sliding events after TSA 
treatment is similar to the mean curvature of the overall MT popu-
lation, we drew a 5-µm-wide box across the cell periphery of a 
representative cell treated with TSA and measured the mean cur-
vature of every MT in this box. The curvature of this population   
of MTs was 121.7 µm
1 (n = 35; Fig. 4 E and Fig. S2 C), which is 
comparable with the curvature of sliding events after TSA treat-
ment (114.4 µm
1). Therefore, ER sliding does not have a prefer-
ence for curved acetylated MTs when compared with straight 
MTs that are also acetylated. Together, these data further support 
the idea that ER sliding favors MTs that are marked by acetylation 
because ER sliding occurs on acetylated MTs even when they are 
not curved. Although MTs from cells treated for 60 min with TSA 
do not appear more curved, we hypothesized that perhaps newly 
acetylated MTs will become curved over a long period of time. 
However, the hyperacetylated MTs were still not significantly more 
curved even 6 h after TSA treatment (Fig. 4 F).
To verify that the effect of TSA treatment on ER sliding 
was caused by the inhibition of HDAC6 rather than another 
member of the HDAC family, we treated cells with a structural 
analogue of the drug tubacin, a specific inhibitor of HDAC6 
(Haggarty et al., 2003). Treatment of COS-7 cells with 10 µM 
tubacin increased MT acetylation by both immunoblot and   
immunofluorescence (Fig. 4, G and H, respectively) in a manner 
and scale similar to TSA, and sliding events also increased in 
number at a rate similar to TSA (Fig. 4 I). These results demon-
strate that the effect on ER sliding is specifically caused by in-
hibition of HDAC6, the MT deacetylase.
The function of ER sliding is not known. One possible role 
of ER sliding would be to allow the ER to probe the cytosol to 
form contacts with other cytoplasmic membrane-bound compart-
ments. By immunofluorescence staining, only 17% of MTs in the 
cell periphery appear heavily acetylated along the majority of 
their length (Fig. 1 H). Some MTs that are not heavily acetylated 
throughout their length have patches of acetylation, which also 
appear in our imaging experiments to serve as regions for ER 
sliding (Fig. 2). Densitometric analysis of immunoblots showed 
that both TSA and tubacin treatment increased MT acetylation by 
four- to sixfold relative to all tubulin (Fig. 4, B and F), indicating JCB • VOLUME 190 • NUMBER 3 • 2010   370
Figure 5.  ER and mitochondria dynamics are coupled, and mitochondrial localization is enriched on acetylated MTs. (A) Merged image of a COS-7 cell 
showing colocalization of mito-dsRed and GFP–Sec61- (left), mito-dsRed and immunolabeled for acetylated -tubulin (middle), and immunolabeled for 
-tubulin and acetylated -tubulin (right). Dashed boxes indicate mitochondria imaged in C. (B) Time-lapse of ER–mitochondria interactions in cells express-
ing GFP–Sec61- and mito-dsRed at the times indicated (see Videos 6–8). Left panel shows an ER tubule moving behind a mitochondrion. Middle panel 
shows a mitochondrion moving behind an ER tubule. Right panel shows massive co-rearrangement of both. Arrows indicate the position of mitochondrion 
(white) or ER (yellow) at each time point. (C, left) As in B. (right) Cells were fixed, immunolabeled with antibodies to -tubulin and acetylated -tubulin, 
and reimaged. Images were merged and shown with indicated colors. (D) As in C, except cells were imaged between t = 8 and t = 10 min after 5 µM 371 ER dynamics occur on acetylated microtubules • Friedman et al.
nocodazole treatment (see Videos 9 and 10). (top) Arrows mark an ER tubule moving behind a dynamic mitochondrion; after fixation it colocalizes with 
acetylated MTs. (bottom) Arrows mark where a dynamic mitochondria tubule grows and retracts, followed by a growing ER tubule on an acetylated MT.   
(E) Percentage of mitochondria that retrospectively colocalize to sites of MT acetylation in untreated cells (77% of 57 total, 72% of 29 static, and 82% of   
28 dynamic mitochondria from 10 cells; left) and cells treated for 10 min with 5 µM nocodazole (71% of 48 total, 59% of 22 static, and 81% of 26 dynamic 
mitochondria from 8 cells; right). (F) Total number of mitochondria from the experiment described in D that are dynamic before (dark gray; n = 36) versus 
after nocodazole treatment (light gray; n = 28). Bars: (A) 10 µm; (B–D) 1 µm.
 
that no more than 25% of tubulin subunits are acetylated in COS-7   
cells (as well as HeLa and U2OS cells; Fig. S3). Because ER slid-
ing dynamics preferentially occur on the subset of MTs that are 
acetylated, we predicted that contacts with other organelles might 
occur at a higher frequency if other organelles are also preferen-
tially bound to and/or moving on acetylated MTs.
ER and mitochondrial dynamics are coupled
Mitochondria interact physically with the ER (Staehelin, 1997; 
Rizzuto et al., 1998; Perktold et al., 2007; de Brito and Scorrano, 
2008; Kornmann et al., 2009), and this interaction is important for 
both lipid synthesis and calcium handling (Csordás et al., 2006; 
Vance, 2008). Mitochondria have been reported to colocalize with 
acetylated MTs in rat astrocytes (Cambray-Deakin et al., 1988) and 
thus were a good candidate to test our model. Mitochondria and ER 
are both dynamic organelles, but it is not clear how much contact 
they maintain while both organelles are moving. To address this, 
COS-7 cells were cotransfected with the ER marker GFP–Sec61- 
and a mitochondrial marker, mito-dsRed (Song et al., 2009), and 
imaged live to visualize the contacts between these two organelles. 
The mitochondria are quite variable in their morphology and dy-
namics (Boldogh and Pon, 2007; Frederick and Shaw, 2007).   
In COS-7 cells, the mitochondria exist as long branched ribbons, 
short tubules, donuts, and spheres; they also range from being static 
over time to moving quite rapidly. However, every mitochondrion we 
visualized (we focused on those in the cell periphery because the 
ER is nicely resolved) appeared to be in direct contact with the ER 
at all times at the resolution of fluorescence microscopy (Fig. 5 A, 
left). The interactions between the ER and mitochondria are main-
tained despite the common dynamic rearrangements experienced 
by both organelles. These coupled dynamics fall into three catego-
ries: (1) an ER tubule moves behind a dynamic mitochondrion,   
(2) a mitochondrion moves behind a dynamic ER tubule, and   
(3) most commonly, the ER is wrapped around a mitochondria rib-
bon, and the two organelles move together with rearrangements 
of both (Fig. 5 B and Videos 6–8). These images show that the dy-
namics of the mitochondrion (Fig. 5 B, white arrows) along with 
the corresponding dynamics of the ER (Fig. 5 B, yellow arrows) 
are tightly interrelated and interconnected and can be maintained 
when both organelles are moving. In fact, even after treatment with 
ionomycin, a drug which disrupts calcium regulation and the mor-
phology of ER (Subramanian and Meyer, 1997) and mitochondria 
(Hom et al., 2007), the vesiculated ER and mitochondria remained 
in contact although both organelles were fragmented (Fig. S4).
Mitochondria preferentially localize to 
regions of MT acetylation
We find that every mitochondrion remains localized to the ER 
during their coupled dynamics (Fig. 5 B and Videos 6–8).   
If acetylated  MTs  play  a  role  in  directing  or  maintaining   
ER–mitochondrial contact, we predicted that the two organelles 
would be found in contact over regions of MTs that are acety-
lated. To test this, cells were cotransfected with GFP–Sec61- 
and mito-dsRed and imaged live on gridded coverslips and then 
quickly fixed and retrospectively immunolabeled for -tubulin 
and acetylated MTs. We show images of the ER and mitochon-
dria from one fixed cell with typical and representative acetyla-
tion staining (Fig. 5 A). Shown in Fig. 5 C are time-lapse images 
of three examples (Fig. 5 A, white dashed boxes) of mitochon-
drial ribbons that remain fairly stationary over at least 2 min and 
also maintain their interaction with the ER. The right panels 
show images of these cells after fixation by immunofluores-
cence. When looking at the entire cell, mitochondrial localiza-
tion correlates well with areas that have the most MT acetylation 
(Fig. 5 A). We quantified the percentage of mitochondria that 
colocalized with acetylated MTs to be 77% (n = 57 mitochon-
dria from 10 cells; Fig. 5 E, left). We next measured whether 
dynamic mitochondria also colocalized at a high frequency along 
acetylated MTs. Indeed, 23 of the 28 (82%) dynamic mitochondria 
we imaged retrospectively appeared to colocalize to acetylated 
MTs (Fig. 5 E, left).
We also visualized colocalization between mitochondria 
and acetylated MTs after 5 µM nocodazole treatment (10 min) 
to depolymerize the bulk of nonacetylated MTs and improve 
our visualization of the acetylated MTs (same conditions as 
shown in Fig. 1 [G and H]). We reasoned that if the mitochon-
dria were bound to acetylated MTs, their position would not be 
expected to drift significantly relative to the acetylated MTs after 
the nonacetylated MTs were depolymerized. Mitochondria   
dynamics were imaged (from t = 8 until t = 10 min after the ad-
dition of 5 µM nocodazole), and cells were fixed and retrospec-
tively immunolabeled. Similar to our observation in untreated 
cells, 71% of all mitochondria in the cell periphery colocalized 
with MTs that were acetylated even after nocodazole treatment 
(n = 48 mitochondria from 8 cells; Fig. 5 E, right). The percent-
age was higher for dynamic mitochondria: 21 out of 26 dynamic 
mitochondria colocalized with acetylated MTs (81%; two ex-
amples are shown in Fig. 5 D and Videos 9 and 10). Together, 
these data demonstrate that the majority of both static and dy-
namic mitochondria localize to at least one acetylated MT.
Mitochondrial dynamics are also relatively insensitive to 
nocodazole-induced MT depolymerization. Of 36 dynamic mi-
tochondria  that  were  discernable  both  before  and  after  no-
codazole, 28 remained dynamic 10 min after nocodazole (78%; 
Fig. 5 F). At this time point, the vast majority of those MTs that 
remained were acetylated (>80%; Fig. 1 H). We show two ex-
amples of mitochondria that moved along an acetylated MT   
after nocodazole treatment by retrospective imaging (Fig. 5 D). 
However, although these data are good evidence that mitochon-
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of ER-localized endosomes localized to acetylated MTs, com-
pared with 14% and 18%, respectively, in untreated cells (Fig. 6 F). 
These data demonstrate by two methods that only a small per-
centage of endosomes localize to acetylated MTs.
Thus, the frequency of endosome–ER contacts on acety-
lated MTs is much rarer than that of ER–mitochondrial contacts 
and matches the distribution that would be expected if the endo-
somes had no preference for acetylated MTs. Together, these data 
suggest that MT acetylation may be a mechanism by which the 
ER can establish and/or maintain contact with mitochondria but 
not endosomes.
Discussion
The ER travels along MTs by two distinct mechanisms in the 
cell, TAC and sliding. Sliding events are much faster than TAC, 
are far more prevalent in the cell (5–10-fold), and occur on a 
subset of MTs that are resistant to nocodazole. However, until 
recently, the mechanism behind ER sliding events had been 
largely unexplored. In this study, we show that ER sliding events 
occur preferentially on acetylated MTs. After nocodazole treat-
ment, TAC events stop before sliding events, and sliding events 
persist when almost all remaining MTs in the cell are acety-
lated. Additionally, ER sliding events can be retrospectively im-
aged to occur on acetylated MTs. Furthermore, both acetylated 
MTs and the MTs on which sliding events occur are highly 
curved when compared with both nonacetylated MTs and dy-
namic MTs, respectively. Finally, increasing the amount of MT 
acetylation in the cell by drug treatment increases the amount of 
ER sliding but not TAC events. Although acetylated MTs have 
been previously shown to be involved in axonal and neurite 
transport (Reed et al., 2006; Hammond et al., 2010) and have a 
potential role in ciliogenesis (Loktev et al., 2008), this is the 
first direct function that has been shown for acetylated MTs in 
the cytoplasm of an epithelial cell.
Why would ER sliding occur preferentially on the subset 
of MTs that are acetylated? Why do cells have different popula-
tions of MTs? We hypothesize that ER dynamics occur on acety-
lated MTs to stimulate ER–ER fusion and ER–mitochondrial 
contacts. ER interactions with mitochondria are important for 
both lipid synthesis and calcium handling in the cell; however, 
little is known about how the ER and mitochondrial membranes 
establish productive contact in the vast cell cytoplasm. Every 
mitochondrion we looked at was already in contact with the ER, 
and our live-imaging data demonstrate quite clearly that mito-
chondria–ER contact sites are maintained even despite the dy-
namics experienced by both organelles. Our retrospective videos 
reveal that both dynamic and static mitochondria localize to 
acetylated MTs, which supports a model that one function of 
ER sliding on acetylated MTs could be to establish and/or main-
tain contact with mitochondria. ER dynamics are strikingly more 
frequent in general than mitochondrial dynamics, and so it is likely 
that the ER finds the mitochondria and not vice-versa.
Like  mitochondria,  Rab5-positive  early  endosomes  are 
often in contact with the ER even during ER dynamics; how-
ever, endosomes do not preferentially localize to acetylated MTs. 
Of the population of endosomes that do not localize to the ER 
it is not clear whether acetylation regulates mitochondrial move-
ment to the same extent as it does the ER because TSA treat-
ment does not increase mitochondrial dynamics (Fig. S5). 
Regardless, a large percentage of mitochondria colocalized to 
regions of MT acetylation, which supports the notion that ER 
sliding on acetylated MTs may establish and/or help maintain 
the integrity of this interorganelle contact.
Endosome–ER contacts are enriched on 
MTs that are not acetylated
Because ER sliding and mitochondrial contacts colocalize prev-
alently to acetylated MTs, we wanted to test whether this is a 
phenomenon particular to all organelles in contact with the ER. 
Endosomes are a dynamic organelle in the cell and have been 
shown to contact the ER (Rocha et al., 2009; Eden et al., 2010). 
To visualize endosomes, we generated a construct expressing 
mCherry fused to an early endosomal marker, Rab5 (Rink et al., 
2005). Endosomes mostly appear as puncta and can be seen dis-
tributed throughout the cell cytoplasm (Fig. 6 A). A large per-
centage of early endosomes appear in contact with the ER at the 
resolution of fluorescence microscopy, and these contacts are 
maintained despite ER and endosome rearrangements and dy-
namics  reminiscent  of  ER–mitochondrial  contacts.  We  show 
three examples of ER–endosome contacts over time in Fig. 6 B.
To test whether early endosomes and ER–endosome contacts 
occur preferentially on regions of the MTs that are acetylated,   
we fixed cells expressing GFP–Sec61- and mCherry-Rab5 and 
stained by immunofluorescence for both acetylated -tubulin and 
-tubulin. We then merged images of endosomal puncta with   
images showing all MTs and acetylated MTs in cells with typical 
acetylation staining (Fig. 6 C). We tested the colocalization of 426 
early endosomes with both MTs and the ER in five different cells 
in the cell periphery where the ER could be resolved. We counted 
238 endosomes (56% of total) that colocalized with MTs and 266 
endosomes (62% of total) that colocalized with the ER (Fig. 6 D). 
Although these numbers may vary from cell to cell, the extent to 
which early endosomes contact the ER is quite significant.
We then determined the percentage of the endosomes that 
are localized to acetylated MTs. Of the 238 MT-localized endo-
somes, only 61 (26%) localized to acetylated MTs (Fig. 6 E). We 
also tested whether the endosomes that are specifically ER local-
ized are found at a higher rate on acetylated MTs. We identified 
162 endosomes (38% of 426 total) that localized to the ER and 
MTs. Of these, only 47 were on acetylated MTs (29% of the 162), 
which is only slightly higher than the value for all endosomes 
(Fig. 6 E). One possible explanation is that as endosomes are traf-
ficked to the ER, a small percentage reaches parts of the ER that 
are localized to acetylated MTs. Interestingly, 18% of endosomes 
that are on MTs, but not ER localized, align with acetylated MTs 
(Fig. 6 E). Together, these data suggest that early endosomes do 
not have a preference for acetylated MTs and are therefore un-
likely to be using acetylated MTs as a primary method to estab-
lish or maintain contact with the ER membrane.
As with mitochondria, we treated cells with 5 µM no-
codazole for 10 min to improve our visualization of acetylated 
MTs. We counted a total of 443 endosomes from five cells fixed 
after nocodazole treatment, and 11% of all endosomes and 15% 373 ER dynamics occur on acetylated microtubules • Friedman et al.
Figure 6.  Early endosomes that interact with the ER are not enriched on acetylated MTs. (A) Merged image of a COS-7 cell showing colocalization of 
mCherry-Rab5 and GFP–Sec61-. Dashed boxes indicate early endosomes imaged in B. (B) Time-lapse images of ER–endosome interactions in cells ex-
pressing GFP–Sec61- and mCherry-Rab5 at the times indicated. Arrows indicate the position of the endosome at each time point. (C) Merged images of a 
fixed COS-7 cell expressing GFP–Sec61- and mCherry-Rab5 and immunolabeled for -tubulin and acetylated -tubulin. Images shown are merges for the 
indicated labels. (D) Table indicating localization of endosomes to ER and MTs. (E) Percentage of MT-localized endosomes that colocalize to acetylated MTs. 
Left bar is total MT localized (n = 61 of 238; 26%), middle bar is ER and MT localized (n = 47 of 162; 29%), and right bar is MT and non-ER localized   
(n = 14 of 76; 18%) from five cells. (F) Percentage of endosomes that colocalize with acetylated MTs before (dark gray) and 10 min after (light gray) 5 µM 
nocodazole (NZ) treatment. Left bars are all endosomes (untreated n = 61 of 426 [14%] from five cells; nocodazole-treated n = 47 of 443 [11%] from five 
cells). Right bars are ER localized (untreated n = 47 of 266 [18%]; nocodazole-treated n = 29 of 198 [15%]). Bars: (A and C) 10 µm; (B) 1 µm.JCB • VOLUME 190 • NUMBER 3 • 2010   374
50 ng mCherry-EB3, 50 ng mito-dsRed, and 1 µg mCherry-Rab5. Cells 
were returned to fresh growth medium 5 h after transfection and were split 
24  h  after  transfection  onto  35-mm  glass-bottom  microscope  dishes  or 
glass-bottom gridded microscope dishes (MatTek) at a density of 2 × 10
5 
cells per dish and allowed to adhere for at least 4 h. Before live-cell imag-
ing, cell medium was changed to OPTI-MEM medium. During drug treat-
ment, cells were treated with 5 µM nocodazole (Acros Organics), 125 nM 
TSA  (Sigma-Aldrich),  10  µM  tubacin  MAZ1370  (provided  by  R.   
Mazitschek and S. Schreiber, Broad Institute, Cambridge, MA), or 2 µM 
ionomycin (Invitrogen).
Immunofluorescence
Cells were fixed with 4% paraformaldehyde (EMS) and 0.5% glutaralde-
hyde (EMS) for 15 min in PBS and permeabilized in 0.1% Triton X-100 
(Thermo Fisher Scientific) in PBS for 5 min. Cells were stained with the indi-
cated primary antibodies and corresponding anti–mouse or anti–rabbit 
secondary antibodies conjugated to Alexa Fluor 405, 488, 555, or 647 
(Invitrogen). Anti–-tubulin was used at 1:500, anti–acetylated tubulin was 
used at 1:200, and all secondary antibodies were used at 1:300.
Confocal microscopy
Imaging of live/fixed cells was performed with an inverted fluorescence 
microscope (TE2000-U; Nikon) equipped with an electron-multiplying charge-
coupled device camera (Cascade II; Photometrics) and a Yokogawa spin-
ning disc confocal system (CSU-Xm2; Nikon). Images were taken with a 100× 
NA 1.4 oil objective, and live imaging was performed at 37°C. Images were 
acquired using MetaMorph (version 7.0; MDS Analytical Technologies)   
and contrasted and merged using Photoshop (Adobe) or MetaMorph. Scale 
bars were generated using either MetaMorph or ImageJ (National Institutes 
of Health).
MT curvature analysis
The length of MTs to be analyzed for curvature was measured using Meta-
Morph, and images of MTs were cropped to the appropriate size. For 
measuring the curvature of acetylated and nonacetylated MTs, this length 
was a total of 5 µm. For measuring ER sliding events, EB3-labeled dynamic 
MTs, and MTs involved in TAC events, this length was a minimum of 2 µm. 
MT curvature was measured by tracing MTs in these cropped images using 
IMOD (Kremer et al., 1996), and “imodcurvature” was used to determine 
the mean curvature of each traced MT.
Western blotting
Whole cell lysates of COS-7 cells were resuspended in Laemmli sample 
buffer, boiled 5 min, separated by SDS-PAGE, and transferred to a poly-
vinylidene fluoride membrane. Antibody against acetylated tubulin was   
used at 1:2,000, and antibody against -tubulin was used at 1:1,000. 
HRP-conjugated goat anti–rabbit or goat anti–mouse secondary antibodies 
were used at 1:3,000. Fluorescence was detected with SuperSignal West 
Pico Chemiluminescent solution (Thermo Fisher Scientific).
Online supplemental material
Fig. S1 shows entire cells used for retrospective ER sliding. Fig. S2 shows 
MT tracings used to determine curvature. Fig. S3 shows the effect of TSA 
treatment on MT acetylation in other cell lines. Fig. S4 shows that contact of 
the ER and mitochondria is maintained despite ionomycin-induced vesicu-
lation of each. Fig. S5 shows that mitochondria dynamics do not increase 
after TSA treatment. Video 1 shows ER dynamics. Videos 2 and 3 show ER   
dynamics before and after nocodazole treatment. Videos 4 and 5 show   
ER dynamics before and after TSA treatment. Videos 6–8 show ER– 
mitochondria coupled dynamics. Videos 9 and 10 show ER and mitochon-
dria dynamics after nocodazole treatment. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200911024/DC1.
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but do localize to the MTs, only 18% are on acetylated MTs. 
Therefore, these endosomes are unlikely to preferentially use 
acetylated MTs to find the ER membrane. A relevant difference 
between endosomes and mitochondria or the ER is that endo-
some movements have been shown in vivo to occur via a kinesin-3 
family member (KIF16B; Hoepfner et al., 2005), whereas mito-
chondria and ER have been shown to traffic using kinesin-1 (Hurd 
and Saxton, 1996; Tanaka et al., 1998; Woźniak et al., 2009). 
Interestingly, kinesin-1 has been shown to have a preference for 
acetylated MTs in COS cells, whereas a kinesin-3 family mem-
ber, KIF1A, does not (Cai et al., 2009). Together, these data suggest 
that different organelles contact the ER through different mecha-
nisms that may be determined by which kinesin motor protein 
they use to bind to MTs.
The proteins responsible for MT acetylation have not yet 
been discovered, but their identity would be helpful for testing   
the functionality of ER sliding and ER–mitochondrial coupling. 
Identifying the ER proteins that link the sliding ER tubule to   
kinesin-1 on acetylated MTs will also be crucial for understand-
ing the role of ER dynamics. Multiple ER proteins that bind MTs 
have been identified that may be responsible (Vedrenne and 
Hauri, 2006) and now can be tested for their colocalization with 
acetylated MTs. Furthermore, although we have touched on one 
potential function of ER sliding as to establish and maintain con-
tact with mitochondria, we assume that it could also play a role in 
trafficking and aid in the dispersion of ER components through-
out the cytoplasm. It remains to be tested whether Golgi and COP 
(coat protein complex) vesicles are also localized to acetylated 
MTs. Our experiments measured colocalization between the ER 
and Rab5-labeled endosomes, and we did not see enrichment on 
acetylated MTs. However, Rab5 endosomes are considered early 
endosomes, and future experiments will need to address whether 
late or recycling endosomes colocalize with the ER on acetylated 
MTs. One clue would be if the structure and or dynamics of these 
organelles have only partial sensitivity to nocodazole treatment 
and colocalize with curved MTs.
Materials and methods
Constructs and antibodies
YFP-STIM1 was a gift from T. Meyer (Stanford University, Palo Alto, CA) via 
A. Palmer (University of Colorado at Boulder, Boulder, CO). Mito-dsRed 
was a gift from D. Chan (California Institute of Technology, Pasadena, CA). 
mCherry-EB3 plasmid was a gift from N. Galjart (Erasmus Medical Center, 
Rotterdam, Netherlands). mCherry–-tubulin was generated by substituting 
mCherry for EYFP in EYFP–-tubulin (Takara Bio Inc.). GFP–Sec61- was 
previously described (Voeltz et al., 2006). mCherry-Rab5 was a gift from 
A. English (University of Colorado at Boulder) and was generated by clon-
ing mCherry into the NheI–BglII sites of pAcGFP1-N1 (Takara Bio Inc.) and 
cloning human Rab5b followed by a stop codon into the BglII–KpnI sites of 
that vector. Antibody to acetylated -tubulin for immunofluorescence and 
Western blotting was purchased from Sigma-Aldrich (6-11B-1). Antibody 
to -tubulin for immunofluorescence was purchased from Abcam. Antibody 
to -tubulin used for Western blotting was purchased from Cell Signaling 
Technology (11H10).
Cell culture, transfection, and drug treatments
COS-7 cells (American Type Culture Collection) were grown in DME sup-
plemented  with  10%  FBS  and  1%  penicillin/streptomycin.  Cells  were 
seeded at 2 × 10
5 cells per well of a 6-well dish for transient transfection. 
Transfections were performed in OPTI-MEM medium (Invitrogen) with 5 µl 
Lipofectamine 2000 (Invitrogen) and the following amounts of plasmid 
DNA: 1–2 µg GFP–Sec61-, 200 ng YFP-STIM1, 125 ng mCherry–-tubulin, 375 ER dynamics occur on acetylated microtubules • Friedman et al.
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